SE359298B - - Google Patents

Info

Publication number
SE359298B
SE359298B SE04228/70A SE422870A SE359298B SE 359298 B SE359298 B SE 359298B SE 04228/70 A SE04228/70 A SE 04228/70A SE 422870 A SE422870 A SE 422870A SE 359298 B SE359298 B SE 359298B
Authority
SE
Sweden
Application number
SE04228/70A
Inventor
S Adams
B Armitage
B Heathcote
N Bristow
Original Assignee
Boots Pure Drug Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Pure Drug Co Ltd filed Critical Boots Pure Drug Co Ltd
Publication of SE359298B publication Critical patent/SE359298B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE04228/70A 1969-03-27 1970-03-25 SE359298B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB06179/69A GB1246902A (en) 1969-03-27 1969-03-27 Improvements in therapeutic agents

Publications (1)

Publication Number Publication Date
SE359298B true SE359298B (sv) 1973-08-27

Family

ID=10072601

Family Applications (1)

Application Number Title Priority Date Filing Date
SE04228/70A SE359298B (sv) 1969-03-27 1970-03-25

Country Status (6)

Country Link
US (1) US3681373A (sv)
CH (1) CH507980A (sv)
DE (1) DE2014847A1 (sv)
FR (1) FR2042294B1 (sv)
GB (1) GB1246902A (sv)
SE (1) SE359298B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2247186A1 (de) * 1972-09-26 1974-03-28 Bayer Ag Antimykotisches mittel
US3949076A (en) * 1975-05-29 1976-04-06 Smithkline Corporation N-(Heterocycl ic-alkyl)-9-xanthenylamines
CN101855554B (zh) * 2007-09-07 2014-05-14 儿童医院医学中心 分泌者、Lewis和唾液酸化抗原水平作为疾病预测指标的用途
EP2451462B1 (en) 2009-07-06 2017-09-06 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
WO2014130789A1 (en) 2013-02-21 2014-08-28 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157658A (en) * 1963-07-05 1964-11-17 Searle & Co 1-carbalkoxy-4-(9-xanthenyl) piperazines and related compounds
US3290313A (en) * 1964-12-29 1966-12-06 Searle & Co 1-carbamoyl-4-xanthenylpiperazines

Also Published As

Publication number Publication date
FR2042294B1 (sv) 1973-12-21
US3681373A (en) 1972-08-01
FR2042294A1 (sv) 1971-02-12
CH507980A (fr) 1971-05-31
GB1246902A (en) 1971-09-22
DE2014847A1 (sv) 1970-10-01

Similar Documents

Publication Publication Date Title
AU465452B2 (sv)
AU450150B2 (sv)
CS149915B2 (sv)
FR2042294B1 (sv)
AU442375B2 (sv)
AU470301B1 (sv)
AU5113869A (sv)
AU442463B2 (sv)
AU442535B2 (sv)
AU442538B2 (sv)
AU442554B2 (sv)
AU442380B2 (sv)
AU442357B2 (sv)
AU470661B1 (sv)
AU4949169A (sv)
CS151578B2 (sv)
CS151542B2 (sv)
AU4540468A (sv)
AU5109569A (sv)
AR203167Q (sv)
AU5077469A (sv)
AU481328A (sv)
AU469091A (sv)
AU4982068A (sv)
AU4953367A (sv)